Bupivicaine Hydrochloride 2.5 mg / mL Injection 30 mL

NDC 51662-1456-01 is also written 51662145601, or 51662-1456-1 (5166214561) in 10-digit form. Reference details for licensed healthcare facility review and verification.

NDC 1151662-1456-01
Product NDC51662-1456
Generic Drug NameBupivicaine Hydrochloride
Brand NameBupivicaine Hydrochloride
ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Strength2.5 mg / mL
Dosage FormInjection
Drug TypeEpidural; Infiltration; Intracaudal; Perineural
Package Quantity30 mL
Package Description30 mL in 1 VIAL, SINGLE-DOSE (51662-1456-1)
Active IngredientsBupivacaine Hydrochloride
Marketing CategoryANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

Bupivicaine Hydrochloride 2.5 mg / mL Injection is tracked under NDC 51662-1456-01 and rolls up into product family 51662-1456. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 30 mL.
  • Manufacturer: HF Acquisition Co LLC, DBA HealthFirst.
  • Dosage form: Injection.
  • Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Bupivicaine Hydrochloride 2.5 mg / mL Injection 30 mL, NDC 51662-1456-01, is a HF Acquisition Co LLC, DBA HealthFirst 2.5 mg / mL injection presentation packaged as 30 mL.

NDC search formats

  • Canonical NDC 11: 51662-1456-01
  • Digits-only NDC 11: 51662145601
  • Possible 10-digit display format: 51662-1456-1 (5166214561)

Helpful product links